Status:

COMPLETED

Thoracoabdominal Arortic CTA Study

Lead Sponsor:

Duke University

Conditions:

Thoracic Aortic Aneurysm

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the contrast agents and imaging techniques used for thoracoabdominal aortic imaging in CT. Imaging parameters and contrast volume are changed and adjusted based...

Eligibility Criteria

Inclusion

  • Patients undergoing thoracoabdominal aortic (TAA) CTA
  • Able to provide informed consent
  • Body Mass Index (BMI) equal to or less than 30

Exclusion

  • Creatinine greater than 2.0
  • Allergy to contrast media
  • Pregnant women

Key Trial Info

Start Date :

January 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT02291718

Start Date

January 1 2014

End Date

September 1 2015

Last Update

April 18 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Medical Center

Durham, North Carolina, United States, 27710

Thoracoabdominal Arortic CTA Study | DecenTrialz